Valuation: Abbott Laboratories

Market Cap 182B 160B 149B 137B 256B 17,388B 261B 1,765B 691B 8,623B 683B 669B 29,793B P/E 2026 *
29.6x
P/E 2027 * 23x
Enterprise Value 205B 180B 168B 154B 289B 19,622B 294B 1,991B 779B 9,731B 771B 754B 33,621B EV / Sales 2026 *
4.08x
EV / Sales 2027 * 3.62x
Free-Float
86.73%
Yield 2026 *
2.48%
Yield 2027 * 2.6%
1 day+5.54%
1 week+1.66%
Current month+15.34%
1 month+15.34%
3 months+11.55%
6 months-22.75%
Current year-22.75%
1 week 101.66
Extreme 101.66
101.66
1 month 88.14
Extreme 88.14
101.66
Current year 82.56
Extreme 82.56
131.6
1 year 82.56
Extreme 82.56
131.6
3 years 82.56
Extreme 82.56
131.6
5 years 82.56
Extreme 82.56
131.6
10 years 82.56
Extreme 82.56
131.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
+5.55%+1.66% - - 182B
+3.15%+5.40%-5.62%-1.64% 108B
+2.57%+5.13%+11.33%+70.79% 60.54B
-4.21%-6.07%+22.50%+49.01% 50.53B
+3.99%+7.38%-9.70%-41.07% 43.79B
+1.83%+3.49% - - 33.57B
+2.41%+0.48%-16.11%-43.26% 28.31B
+2.13%-5.83%+31.24%-7.44% 23.31B
+4.36%+7.63%+0.61%-0.93% 21.28B
+1.78%+0.95%-11.55%+0.68% 20.27B
Average +2.35%-1.01%+2.84%+3.27% 43.27B
Weighted average by Cap. +3.10%-0.24%+2.37%+9.51%

Financials

2026 *2027 *
Net sales 50.29B 44.13B 41.1B 37.8B 70.86B 4,804B 72.07B 488B 191B 2,383B 189B 185B 8,232B 54.63B 47.94B 44.64B 41.06B 76.97B 5,219B 78.29B 530B 207B 2,588B 205B 201B 8,943B
Net income 6.32B 5.55B 5.16B 4.75B 8.9B 604B 9.06B 61.27B 23.98B 299B 23.72B 23.21B 1,034B 7.94B 6.97B 6.49B 5.97B 11.19B 759B 11.39B 77.02B 30.15B 376B 29.83B 29.18B 1,300B
Net Debt 23.38B 20.52B 19.11B 17.57B 32.95B 2,234B 33.51B 227B 88.73B 1,108B 87.78B 85.88B 3,827B 15.74B 13.82B 12.87B 11.83B 22.18B 1,504B 22.56B 153B 59.75B 746B 59.11B 57.83B 2,577B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
26-07-23 US$101.66 0.00%
26-07-27 US$101.66 0.00%
26-07-24 US$101.66 0.00%
26-07-22 US$101.66 0.00%
26-07-21 US$101.66 +1.66%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
104.49USD
Average target price
119.12USD
Spread / Average Target
+14.01%

Quarterly revenue - Rate of surprise